Stockreport

FDA approves Alvotech and Teva's SELARSDI for new indications [Yahoo! Finance]

Alvotech  (ALVO) 
PDF SELARSDI, a human monoclonal antibody, targets the p40 protein found in interleukin (IL)-12 and IL-23 cytokines - key in immune-mediated diseases. It is developed and [Read more]